TrialCancer discovery2017

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.

Jon S Zawistowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.